Paumgartner G - Search Results

1

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.

Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G. Beuers U, et al. Among authors: paumgartner g. Hepatology. 1992 Sep;16(3):707-14. doi: 10.1002/hep.1840160315. Hepatology. 1992. PMID: 1505913 Clinical Trial.

2

Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.

Paumgartner G, Beuers U. Paumgartner G, et al. Hepatology. 2002 Sep;36(3):525-31. doi: 10.1053/jhep.2002.36088. Hepatology. 2002. PMID: 12198643 Review.

3

Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.

Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Beuers U, et al. Among authors: paumgartner g. Hepatology. 1992 Apr;15(4):603-8. doi: 10.1002/hep.1840150409. Hepatology. 1992. PMID: 1551637

4

Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.

Beuers U, Fischer S, Spengler U, Paumgartner G. Beuers U, et al. Among authors: paumgartner g. J Hepatol. 1991 Jul;13(1):97-103. doi: 10.1016/0168-8278(91)90870-h. J Hepatol. 1991. PMID: 1918882

5

Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.

Sackmann M, Pauletzki J, Aydemir U, Holl J, Sauerbruch T, Hasford J, Paumgartner G. Sackmann M, et al. Among authors: paumgartner g. Hepatology. 1991 Dec;14(6):1136-41. Hepatology. 1991. PMID: 1959863 Clinical Trial.

6

Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.

Spengler U, Pape GR, Hoffmann RM, Johnson JP, Eisenburg J, Paumgartner G, Riethmüller G. Spengler U, et al. Among authors: paumgartner g. Hepatology. 1988 May-Jun;8(3):459-62. doi: 10.1002/hep.1840080304. Hepatology. 1988. PMID: 3371866

7

Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy.

Sauter G, Beuers U, Paumgartner G. Sauter G, et al. Among authors: paumgartner g. Digestion. 1995;56(6):523-7. doi: 10.1159/000201286. Digestion. 1995. PMID: 8536824

8

Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells.

Kullak-Ublick GA, Beuers U, Paumgartner G. Kullak-Ublick GA, et al. Among authors: paumgartner g. Hepatology. 1996 May;23(5):1053-60. doi: 10.1002/hep.510230518. Hepatology. 1996. PMID: 8621133

9

Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.

Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Sauter G, et al. Among authors: paumgartner g. Hepatology. 1996 Jul;24(1):123-6. doi: 10.1053/jhep.1996.v24.pm0008707250. Hepatology. 1996. PMID: 8707250

10

Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications.

Beuers U, Boyer JL, Paumgartner G. Beuers U, et al. Among authors: paumgartner g. Hepatology. 1998 Dec;28(6):1449-53. doi: 10.1002/hep.510280601. Hepatology. 1998. PMID: 9828205 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters